William Frank Hulse IV - Mar 10, 2025 Form 4 Insider Report for MIMEDX GROUP, INC. (MDXG)

Role
General Counsel and CAO
Signature
/s/William F. Hulse
Stock symbol
MDXG
Transactions as of
Mar 10, 2025
Transactions value $
-$635,279
Form type
4
Date filed
3/12/2025, 07:56 PM
Previous filing
Mar 5, 2025
Next filing
Mar 14, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MDXG Common Stock Sale -$635K -81.4K -14.13% $7.80 495K Mar 10, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding MDXG Stock Options 108K Mar 10, 2025 Common Stock 108K $8.30 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale price indicated is a weighted average sale price. The corresponding shares were sold in multiple transactions at prices ranging from $7.74 to $7.96, inclusive. The reporting person undertakes to provide to MiMedx Group, Inc., any security holder of MiMedx Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
F2 The exercise price of the Stock Options awarded on March 3, 2025 as stated in the Reporting Person's Form 4 filed March 5, 2025 inadvertently included a typographical error. This Form 4 accurately states the exercise price for the Stock Options awarded to the Reporting Person on March 3, 3025.
F3 The options granted to the reporting person shall vest 25% on each anniversary of the grant date, subject to the reporting person's continued employment as specified in the Nonqualified Stock Option Agreement..